Spire Healthcare Group (LON:SPI) Stock Rating Reaffirmed by Jefferies Financial Group

Spire Healthcare Group (LON:SPI)‘s stock had its “hold” rating reaffirmed by research analysts at Jefferies Financial Group in a report issued on Friday, Stock Target Advisor reports.

A number of other research analysts have also recently issued reports on SPI. Royal Bank of Canada reaffirmed an “outperform” rating and issued a GBX 149 ($1.95) price target on shares of Spire Healthcare Group in a report on Monday, September 9th. Peel Hunt reaffirmed an “add” rating on shares of Spire Healthcare Group in a report on Friday, November 1st. Peel Hunt reaffirmed an “add” rating and issued a GBX 155 ($2.03) price target on shares of Spire Healthcare Group in a report on Monday, September 16th. Liberum Capital lifted their price target on Spire Healthcare Group from GBX 115 ($1.50) to GBX 120 ($1.57) and gave the company a “hold” rating in a report on Tuesday, November 12th. Finally, Barclays reaffirmed an “underweight” rating and issued a GBX 115 ($1.50) price target on shares of Spire Healthcare Group in a report on Friday, August 9th. Two investment analysts have rated the stock with a sell rating, six have issued a hold rating and two have given a buy rating to the stock. The stock has a consensus rating of “Hold” and an average target price of GBX 131 ($1.71).

Shares of LON SPI traded up GBX 5.20 ($0.07) during midday trading on Friday, reaching GBX 118 ($1.54). 313,309 shares of the company traded hands, compared to its average volume of 1,770,000. The stock’s 50-day simple moving average is GBX 118.29 and its 200-day simple moving average is GBX 117.18. The company has a debt-to-equity ratio of 120.55, a quick ratio of 0.90 and a current ratio of 1.15. Spire Healthcare Group has a 12 month low of GBX 95.25 ($1.24) and a 12 month high of GBX 141 ($1.84). The firm has a market cap of $471.67 million and a PE ratio of 29.50.

About Spire Healthcare Group

Spire Healthcare Group plc, together with its subsidiaries, owns and operates private hospitals and clinics in the United Kingdom. It provides a range of integrated surgical, medical, and diagnostic services. The company offers various treatments in the areas of allergy and infectious diseases, blood tests, bones and joints, bowel treatments, breast screening and surgery, cancer investigations and treatments, cosmetic surgery, cyst removal, and dental surgery, as well as ear, nose, and throat treatments.

See Also: Stock Symbols, CUSIP and Other Stock Identifiers

Analyst Recommendations for Spire Healthcare Group (LON:SPI)

Receive News & Ratings for Spire Healthcare Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Spire Healthcare Group and related companies with MarketBeat.com's FREE daily email newsletter.